Strategy, formerly known as MicroStrategy, recently acquired 13,390 bitcoins between May 5-11, at an average price of $99,856, adding $1.34 billion worth of Bitcoin $0.00004 to its reserves. This acquisition increased the company’s total Bitcoin holdings to 568,840 BTC, valued at over $59 billion. Although the average cost for the reserves remains at $69,287, paper gains reach $20 billion. The company now possesses roughly 2.7% of the total Bitcoin supply, highlighting its substantial purchase of 303,230 BTC over the last six months.
Strategy’s Bitcoin Purchases Intensify
The firm funded its latest Bitcoin acquisition through proceeds from stock sales of its common stock (MSTR) and preferred shares labeled STRK. Last week, Strategy sold 3.22 million MSTR shares for $1.31 billion. At present, an authorization for additional stock issuance worth $19.69 billion is still in place. The STRK section generated $25.1 million from selling 273,987 shares, with an additional $20.85 billion sales limit available.

The company’s “42/42” program aims to accumulate Bitcoin with a total capital increase of $84 billion by 2027. Initially declared at $42 billion, the plan was later doubled. Chairman Michael Saylor hinted at another acquisition file last Sunday by saying “connect the dots.” Just a week prior, the firm purchased 1,895 BTC for $180 million, raising their total holdings to 555,450 BTC.
Currently, at least 70 publicly traded companies have adopted the “Bitcoin treasury” model, with giants like Cantor Fitzgerald and SoftBank intensifying the competition with their $3.6 billion Twenty One initiative. Bernstein analysts predict an inflow of $330 billion worth of BTC into institutional portfolios within five years.
Strategy’s Future Plans and Associated Risks
Strategy’s market capitalization of $113.7 billion values nearly double the net Bitcoin asset value. As per K33, the stock’s strong premium since the end of 2024, preserved despite dilution exceeding $15 billion, gives the company an advantage for future acquisitions.
Its low debt ratio and payments not due until 2028 keep leverage concerns limited for now. Benchmark reiterated a “buy” recommendation for MSTR with a $650 target, while Bernstein maintained its “outperform” rating with a $600 target.